Biomimetic functionalization of nanoparticles through camouflaging with cellular membranes
has emerged as a promising strategy for cancer theragnostics. Cellular membranes used for …

The management of aggressive breast cancer, particularly, triple negative breast cancer
(TNBC) remains a formidable challenge, despite treatment advancement. Although newer …

Erythrocytes are the most abundant cells in the blood. As the results of long‐term natural
selection, their specific biconcave discoid morphology and cellular composition are …

Paclitaxel (PTX) belongs to a class of taxane anti-tumor drug used for the clinic treatment of
breast cancer, ovarian cancer, non-small-cell lung cancer, and so on. PTX has poor water …

Biomimetic nanoplatform being a recent and emerging strategy plays an important role in a
wide variety of applications. The different types of membranes used for coating include …

Drugs are referred to as drug nanocrystals when they exist as nanoscale crystal structures.
This kind of nanocarrier has been widely utilized to increase the solubility and absorption for …

Nanoerythrocytes membrane (NEs) has recently been used to improve pharmacokinetics
and biodistribution for successful drug therapy. NEs intended to enhance the drug targeting …

Herein, the use of red blood cells (RBCs) as carriers of cytoplasmically interned
phototherapeutic agents is described. Photolysis promotes drug release from the RBC …

The hydrophobicity has been known as a pivotal factor limiting the therapeutic capacity of
cancer drugs. Biocompatible nanocarriers as a potential platform for drug delivery can …

Nano-erythrocyte coating has been developed as an interesting biomimetic platform to
provide hybrid nano-carriers with innate functions to target liver cancer. This goal was …